Breast Implants companies are increasingly expanding their business

• Published Month : Monday, 26 Aug 2019 08:12 pm

North America is leading the Breast Implants market and it is anticipated to be the highest revenue contributor by 2027. Rising prevalence of the breast implants surgery is expected to fuel breast implants market in North America.

The breast implants market is highly competitive in nature with considerable number of players, having a high level of consolidation overall revenue share. Most of the companies operating in the breast implants market are present globally and have wide distribution and sales network through partnerships or authorized dealers.

The most notable market participants are Allergan plc., Mentor Worldwide LLC (J&J), GC Aesthetics, Sientra, Inc., POLYTECH Health & Aesthetics GmbH, Ideal Implant Incorporated, Silimed, Group Sebbib SAS, Guangzhou Wanhe Plastic Materials Co., Ltd, and HANSBIOMED CO. LTD. occupying a considerable share of the market owing to their offerings to the market.

Market leaders are involved in expanding their business through organic or inorganic activities such as, acquisition, product launches and product approval. For instance, in 2017, Allergan plc. has carried out various important business developments such as acquisition of Keller Medical, Inc., Zeltiq Aesthetics, Inc., and LifeCell Corporation. The acquisitions have helped the company positively to expand their product offerings as well as expand their consumer base at a global level. Additionally, in January 2017, Allergan received FDA approval for the commercialization of to market NATRELLE INSPIRA SoftTouch breast implants, which provides women undergoing breast reconstruction, augmentation or revision surgery a new medium firmness gel. Subsequently, these activities are expected to provide the market with lucrative growth opportunities.

The global breast implants market accounted to US$ 1,475.7 Mn in 2018 and is expected to grow at a CAGR of 5.4% during the forecast period 2019 – 2027, to account to US$ 2,338.6 Mn by 2027.

Many well-known as well as small local companies are present in the market to provide diversified product to its customers. The larger firms are adopting the strategy of acquiring small firms to enhance its product portfolio and expand its footprint in different geographies. Additionally various companies are also undergoing other strategic alliances such as collaboration, agreements and partnerships to garner their significance and remain competitive in the market. Some of the important key developments from the industryinclude Allergan acquired LifeCell Corporation which is a regenerative medicine company. The acquisition will combine regenerative medicines business, LifeCell's novel with the Allergan’s products such as breast implants and tissue expanders and medical aesthetics. 

Sientra acquired Specialty Surgical Products, Inc. (SSP), with this acquisition the company will enhance it product portfolio of Dermaspan and AlloX2 lines of breast tissue expanders products. Establishment Labs has entered into a partnership with Puregraft. The agreement is made to provide additional option of distribution of the Puregraft’s products in the US and Canada and also to transfer autologous fat transfer products of Puregraft.